About our President & Chief Science Officer

Dr. Mina Izadjoo

Mina Izadjoo, Ph.D.


Dr. Mina Izadjoo is the "President and Chief Science Officer” of integrated Pharma Services.


Formerly, she was The "Chief Science Officer" and Laboratory Director of Trideum Biosciences.


She served as a “Senior Distinguished Scientist” and Director of the Diagnostics and Translational Research Center (DTRC) of the Henry M. Jackson Foundation (HJF) for Advancement of Military Medicine.


She served as the Chief of Wound Biology and Translational Research (WBTR) Division at the Armed Forces Institute of Pathology (AFIP) in the Washington, DC prior to her position at HJF. While at AFIP, she was awarded the title of “Distinguished Scientist” in accordance with the Public Law 94-36 for demonstrated ability and experience to enhance the activities of the AFIP in consultation, education, and research. .


Dr. Izadjoo received her PhD in Microbiology in 1992 from Louisiana State University. This was followed by six years of post-doctoral fellowships at Texas A&M University and NIH in molecular biology and immunogenetics.


Her research efforts have mostly been focused on developing and evaluating diagnostics and therapeutics research.


Dr. Izadjoo who holds an Associate Professorship at Uniformed Services University for Health Sciences (USUHS) is the recipient of numerous awards including the 2011 Biological Sciences Award from the Washington Academy of Sciences.


She currently is an advisor to a number of industry partners and serves in the Advisory Board of the Anna Mendez University System in Puerto Rico. Dr. Izadjoo is the current President of the Washington Academy of Sciences.